SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Medbox Inc (OTCMKTS:MDBX) CEO Jeff Goh sent a letter to the company’s founder, Vincent Mehdizadeh in which he highlighted a new business model for the company. According to the letter the, proposed business model is very different from the current model.

The model

According to Mr. Goh, the current model revolves around providing specialized services to various operators in the Marijuana industry. Most of the players include cultivation centers, licensed marijuana clinics, research facilities and manufacturers. The letter points out that there is a need to shift to a new strategy especially because of the new found acceptance for medical marijuana.

The letter also pointed out that Medbox Inc (OTCMKTS:MDBX) is heavily committed to offering the best services to its clients. The firm, therefore, has to evolve for it to secure a solid position at the top. The fundamental goal of the firm is to become the best provider to patients in areas where the drug has been legalized.

Highlight

Jeff Goh is currently working as the company’s interim CEO. Medbox Inc (OTCMKTS:MDBX) provides various services including licensing, compliance and consultation. It has been particularly keeping on the growing marijuana market. The company’s gamble on the marijuana industry also seems to be paying off well and is headed in the right direction. In the current year alone, there have been numerous discussion and meetings concerning marijuana and its medical uses.

The firm also benefits from the dedicated management team and influential ambassadors such as Jennifer Love, Ned Siegel, and Mitch Lowe. The positive situation has also extended to the stock performance. Medbox Inc (OTCMKTS:MDBX) stock surged more than 10% at the close of the last trading session. The profits were derived from a 3.89 million share volume. The firm’s average monthly share volume is 5.15 million.